Medical Properties Trust (MPT)

NYSE Real Estate Health Care REITs S&P SmallCap 600
$1.81
-0.07 (-3.72%)
Close of Nov 06, 2026 · end-of-day data
Source: Medical Properties Trust's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$541.14M$704.75M$784.52M$854.20M$1.25B$1.54B$1.54B$871.80M$995.55M$972.02M
Cost of revenue——$84.17M$168.21M$30.14M$101.44M$167.42M$110.07M$74.17M$90.31M
Gross profit——$700.35M$685.99M$1.22B$1.44B$1.38B$761.73M$921.38M$881.72M
Operating income$341.64M$485.58M————————
Interest expense$159.60M$176.95M$223.27M$237.83M$328.73M$367.39M$359.04M$411.17M$417.82M$510.36M
Pre-tax income$219.11M$293.92M$1.02B$373.78M$463.33M$730.89M$959.72M-$686.77M-$2.36B-$237.32M
Income tax-$6.83M$2.68M$927.00K-$2.62M$31.06M$73.95M$55.90M-$130.68M$44.10M$38.62M
Net income$225.05M$289.79M$1.02B$374.68M$431.45M$656.02M$902.60M-$556.48M-$2.41B-$277.05M
EBITDA$439.24M$617.56M————————
EPS (basic)$0.86$0.82$2.77$0.87$0.81$1.11$1.50$-0.93$-4.02$-0.46
EPS (diluted)$0.86$0.82$2.76$0.87$0.81$1.11$1.50$-0.93$-4.02$-0.46
Diluted shares261.07M350.44M366.27M428.30M530.46M590.14M598.84M598.52M600.25M600.89M
Gross margin——89.3%80.3%97.6%93.4%89.1%87.4%92.6%90.7%
Operating margin63.1%68.9%————————
Net margin41.6%41.1%129.6%43.9%34.5%42.5%58.5%-63.8%-242.1%-28.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$83.24M$171.47M$820.87M$1.46B$549.88M$459.23M$235.67M$250.02M$332.33M$540.86M
Total assets$6.42B$9.02B$8.84B$14.47B$16.83B$20.52B$19.66B$18.30B$14.29B$15.00B
Long-term debt$2.91B$4.90B$4.04B$7.02B$8.87B$11.28B$10.27B$10.06B$8.85B$9.70B
Total debt$2.91B$4.90B$4.04B$7.02B$8.87B$11.28B$10.27B$10.06B$8.85B$9.70B
Total liabilities$3.17B$5.19B$4.28B$7.44B$9.49B$12.07B$11.06B$10.67B$9.46B$10.39B
Shareholders' equity$3.25B$3.82B$4.55B$7.03B$7.34B$8.44B$8.59B$7.63B$4.83B$4.61B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$263.84M$362.24M$449.09M$494.12M$617.64M$811.66M$739.01M$505.79M$245.48M$230.77M
Free cash flow$263.84M$362.24M$449.09M$494.12M$617.64M$811.66M$739.01M$505.79M$245.48M$230.77M
Investing cash flow-$926.54M-$2.36B$564.18M-$4.88B-$2.95B-$3.86B$396.06M$517.56M$1.32B-$264.74M
Financing cash flow$552.56M$2.07B-$345.87M$5.04B$1.40B$2.95B-$1.34B-$1.02B-$1.48B$228.08M
Share buybacks——————$17.94M——$23.44M
Stock-based compensation$7.94M$9.95M$16.50M$32.19M$47.15M$52.11M$49.42M$33.25M$32.98M$25.75M
Depreciation & amortization$97.60M$131.98M$141.49M$156.57M$275.95M$333.78M$345.58M$616.13M$453.75M$272.82M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.